U.S. Markets close in 1 hr 13 mins

Hologic, Inc. (HOLX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
45.82+0.33 (+0.73%)
As of 2:46PM EDT. Market open.
People also watch
ISRGHSICXRAYVARIDXX

Hologic, Inc.

250 Campus Drive
Marlborough, MA 01752
United States
508-263-2900
http://www.hologic.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees5,333

Key Executives

NameTitlePayExercisedAge
Mr. Stephen P. MacMillanChairman, Chief Exec. Officer and Pres3.54MN/A53
Mr. Robert W. McMahonChief Financial Officer1.31MN/A48
Mr. Eric B. ComptonChief Operating Officer1.35MN/A52
Mr. John M. GriffinGen. Counsel1.19MN/A56
Mr. Peter J. Valenti IIIDivision Pres of Breast & Skeletal Health Solutions1.15M77.71k54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, Procleix family of assays for blood screening, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test. The Breast Health segment offers breast imaging and related products and accessories, including digital and film-based mammography systems; computer-aided detection (CAD) for mammography; invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. This segment also provides Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View that provides a 2D image; Selenia digital mammography platform; and SecurView Workstation. The GYN Surgical segment offers NovaSure system to treat women suffering from abnormal uterine bleeding; and MyoSure system for the hysteroscopic removal of fibroids. The Skeletal Health segment provides discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient’s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

Corporate Governance

Hologic, Inc.’s ISS Governance QualityScore as of June 2, 2017 is 7. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.